FDA Grants AP Status for Metformin Hydrochloride ANDA217631 by Laurus
The FDA has granted approval status (AP) for ANDA217631, a supplemental application for Metformin Hydrochloride submitted by Laurus.
Asset / Drug
Drug and asset intelligence for Laurus with 7 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.